GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABION Inc (XKRX:203400) » Definitions » Asset Impairment Charge

ABION (XKRX:203400) Asset Impairment Charge : ₩0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is ABION Asset Impairment Charge?

ABION's Asset Impairment Charge for the three months ended in Mar. 2024 was ₩0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was ₩0 Mil.


ABION Asset Impairment Charge Historical Data

The historical data trend for ABION's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABION Asset Impairment Charge Chart

ABION Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only - - - - -

ABION Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ABION Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.


ABION Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of ABION's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


ABION (XKRX:203400) Business Description

Traded in Other Exchanges
N/A
Address
9th FI, HanWha Biz Metro Building, 242 Digital-ro, Guro-gu, Seoul, KOR, 08394
ABION Inc is a biopharmaceutical company. It is primarily involved in the research and development new bio pharmaceutical drugs and companion diagnostics systems for the treatment of incurable diseases.

ABION (XKRX:203400) Headlines

No Headlines